Merck has strong quarter even as COVID-19 treatment tumble
Merck beat first-quarter expectations and hiked its 2023 forecast even as sales plunged for its COVID-19 treatment and a strong dollar hurt revenue.
#merck
Merck has strong quarter even as COVID-19 treatment tumble
Upworthy
0 shares
1 views
You might like
Related news coverage
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
Strong sales of blockbuster drugs Keytruda and Gardasil helped Merck & Co. Inc. post better-than-expected first-quarter results on..
Upworthy
Merck has strong quarter even as COVID-19 treatment tumble
Merck beat first-quarter expectations and hiked its 2023 forecast even as sales plunged for its COVID-19 treatment and a strong..
SeattlePI.com